Rasio utang jangka dawa marang modal Theriva Corp (TOVX)

Theriva Biologics, Inc. (TOVX) possesses significant market influence due to the development of unique adenoviruses that destroy tumors from within. This daily price chart for Theriva Biologics, Inc. (TOVX) reflects the asset's dynamics, with a metric of 0.25. The business relies on the creation of antiviral agents and microbiome correction within US laboratories. Meanwhile, the company minimizes operational risks by delegating clinical trials to specialized external contractors.

Theriva Biologics, Inc. (TOVX) invests in the development of oncolytic viruses and microbiome protection to combat cancer. This long-term financial debt sustainability indicator reflects the value of loans with maturities exceeding one year per unit of equity. The metric measures the company's reliance on external borrowing when implementing complex scientific projects. Low values confirm the autonomy of research funding, which reduces the risk of default during market shocks.